The hematological micronucleus test is regarded as an indicator of the clastogenic effect of chemicals and acute cytogenetic damage. The test can be carried out in red blood cells of the bone marrow and of the spleen, as well as in peripheral erythrocytes. We have determined the precise background values of micronucleated red blood cells for the peripheral blood of BALB/c, DBA/2, and NMRI mice. Bleeding, phenylhydrazine-induced hemolysis, and splenectomy generated an increase of micronucleated erythrocytes in the peripheral blood of mice. Our data thus demonstrate that such factors should be taken into consideration when the micronucleus test is used for screening the genotoxic potential of chemicals. Furthermore, the micronucleus-inducing effect of cyclophosphamide was studied in normal and splenectomized mice and, in addition, a comparison of the sensitivity of the micronucleus test was carried out in peripheral blood and bone marrow after cyclophosphamide treatment. Our data demonstrate that the kinetics of micronucleus formation were similar in normal and in splenectomized mice in which the micronucleus levels had returned to normal. The comparison of micronucleus formation in bone marrow and peripheral blood after cyclophosphamide treatment revealed the generation of similar quantities of micronucleated red blood cells in both tissues. The physiological mechanisms of micronucleus formation and removal and the potential role of chemically induced spleen damage during this process are discussed; the usefulness of the peripheral micronucleus test as a simple, rapid, and animal-saving modification of the standard bone marrow test is evaluated.
Similar content being viewed by others
Abbreviations
- CP:
-
cyclophosphamide
- MN:
-
micronuclei
- MNCE:
-
micronucleated normochromatic erythrocytes
- MNPCE:
-
micronucleated polychromatic erythrocytes
- MNRBC:
-
micronucleated red blood cells
- NCE:
-
normochromatic erythrocytes
- PCE:
-
polychromatic erythrocytes
References
BEGEMANN, H. (1977). Praktische Haematologie. Georg Thieme Verlag, Stuttgart.
BRODSKY, I., DENNIS, L.H., KAHN, S.B. and BRADY, L.W. (1966). Normal mouse erythropoiesis. I. The role of the spleen in mouse erythropoiesis. Cancer Res. 26: 198–201.
CLAYSON, D.B., BIANCIFIORI, C., MILIA U., and GIORNELLI-SANTILLI, F.E. (1966). The induction of pulmonary tumours in Balb/c/Cb/Se Mice by Derivatives of Hydrazine. In: Lung Tumours in Animals, Proceedings of the Quadrennial Conference on Cancer, University of Perugia Department of Cancer Research (L. Severi, ed.), pp. 869–880. Perugia, Italy.
CROSBY, W. H. (1959). Normal functions of the spleen relative to red blood cells: A review. Blood 14: 399–408.
HEDDLE, J.A., HITE, M., KIRKHART, B., MAVOURNIN, K. MAC GREGOR, J.T., NEWELL, G.W. and SALAMONE, M.F. (1983). The induction of micronuclei as a measure of genotoxicity. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutation Res. 123: 61–118.
MAC GREGOR, J.T., WEHR, C.M. and GOULD, D.H. (1980). Clastogen-induced micronuclei in peripheral blood erythrocytes: the basis of an improved micronucleus test. Environ. Mutagen 2: 509–514.
MAC GREGOR, J.T., SCHLEGEL, R., CHOY, W.N., and WEHR, C.M. (1983). Micronuclei in circulating erythrocytes: A rapid screen for chromosomal damage during routine toxicity testing in mice. In: Developments in the Science and Practice of Toxicology (A. W. Hayes, R.C. Schnell and T.S. Miya, eds.), pp. 555–558. Elsevier, Amsterdam.
MAIER, P. and SCHMID, W. (1976). Ten model mutagens evaluated by the micronucleus test. Mutation Res. 40: 325–338.
PANNACCIULI, I.M., MASSA, G.G., SAVIANE, A.G., GHIO, R.L., BIANCHI, G.L. and BOGLIOLO, G.V. (1977). Effect of bleeding on in vivo and in vitro colony-forming hemopoietic cells. Acta Haemat. 58: 27–33.
PAPAYANNOPOULOU, T. and FINCH, C.A. (1975). Radioiron measurements of red cell maturation. Blood Cells 1: 535–546.
PARODI, S., de FLORA, S., CAVANNA, M., PING, A., ROBBIANO, L., BENNICELLI, C. and BRAMBILLA, G. (1981). DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity. Cancer Res 41: 1469–1482.
SALAMONE, M., HEDDLE, J., STUART, E., and KATZ, M. (1980). Towards an improved micronucleus test. Studies on 3 model agents, mitomycin C, cyclophosphamide and dimethylbenzanthracene. Mutation Res. 74: 347–356.
SCHALM, O.W. (1966). Veterinary Hematology, 2nd ed Lea and Febiger, Philadelphia.
SCHLEGEL, R. and MAC GREGOR, J.T. (1982). The persistence of micronuclei in peripheral blood erythrocytes: detection of chronic chromsome breakage in mice. Mutation Res. 104: 367–369.
SCHMID, W. (1975). The micronucleus test. Mutation Res. 31: 9–15.
SHINDO, Y., HIRANO, F. MAEDA, H. and TAKEDA, U. (1983). The micronucleus test with mouse spleen cells. Mutation Res. 121: 53–57.
SIMPSON, C.F. and KLING, J.M. (1967). The mechanism of denucleation in circulating erythroblasts. J. Cell Biol. 35: 237–245.
TOTH, B. (1975). Synthetic and naturally occurring hydrazine as possible cancer causative agents. Cancer Res. 35: 3693–3697.
VON EHRENSTEIN, G. and LOCKNER, D. (1958). Sites of the physiological breakdown of the red blood corpuscles. Nature 181: 911.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Steinheider, G., Neth, R. & Marquardt, H. Evaluation of nongenotoxic and genotoxic factors modulating the frequency of micronucleated erythrocytes in the peripheral blood of mice. Cell Biol Toxicol 1, 197–211 (1985). https://doi.org/10.1007/BF00120164
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00120164